Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06541340
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-30
Brief Title:
A New Strategy for Preoperative Drainage of Resectable Pancreatic Head Cancer Combined Severe Obstructive Jaundice
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A New Strategy for Preoperative Drainage of Resectable Pancreatic Head Cancer Combined Severe Obstructive Jaundice a Multicenter Open-label Randomized Controlled Clinical Study
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PROB
Brief Summary:
Severe obstructive jaundice caused by pancreatic head cancer usually requires preoperative biliary drainage but its necessity and effectiveness are controversial and specific strategies lack clear standards This study proposed a new strategy for preoperative biliary drainage using serum prealbumin as the main evaluation index and compared it with the traditional strategy using serum total bilirubin as the main evaluation index Through a randomized controlled multicenter prospective study we explored the effects of different drainage strategies on the incidence of in-hospital complications and long-term prognosis of patients with resectable pancreatic head cancer guided clinical decisions on preoperative drainage time and surgical timing and provided high-quality evidence-based medicine for preoperative biliary drainage of pancreatic head cancer
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None